Global Study: COVID-19 And Adenoviral Vaccines Tied To GBS Risk, Not MRNA Vaccines
GBS is a rare but serious neurological condition that can cause progressive limb weakness and eventual paralysis, with an annual incidence of 1 to 4 cases per 100,000 people worldwide. It has been linked to various infections, including Campylobacter …
Large-scale study in a population covering more than 230 million people sheds light on the relationship between Guillain-Barré syndrome after COVID-19 vaccines or SARS-CoV-2 infection.
Auckland, 29 May 2025 – A new multinational study analysing data from over 230 million people across 20 global sites highlights the relationship between SARS-CoV-2 infection, certain COVID-19 vaccines, and Guillain-Barré syndrome (GBS). This research reinforces the importance of continuous vaccine safety monitoring and highlights key differences in risk associated with different vaccine types.
GBS is a rare but serious neurological condition that can cause progressive limb weakness and eventual paralysis, with an annual incidence of 1 to 4 cases per 100,000 people worldwide. It has been linked to various infections, including Campylobacter jejuni, Zika virus, influenza, and SARS-CoV-2.
The study used advanced epidemiological methods and healthcare data from 20 sites within GVDN: seven sites from the African COVID-19 Vaccine Safety Surveillance (ACVaSS) system: Ethiopia, Ghana, Kenya, Malawi, Mali, Mozambique, and Nigeria; Argentina; New South Wales and Victoria in Australia; British Columbia and Ontario in Canada; Denmark; Finland; Indonesia; Republic of Korea; South Africa; and three Vaccine monitoring Collaboration for Europe (VAC4EU) sites: Catalonia and Valencia in Spain, and the United Kingdom.
People infected with SARS-CoV-2 were around three times more likely to develop Guillain-Barré syndrome (GBS) within six weeks of infection compared to other times, suggesting that infection with this virus increases the risk of GBS. An increased risk was also observed following adenoviral vector vaccines (AstraZeneca, Janssen/Johnson & Johnson), but not after mRNA vaccines (Pfizer-BioNTech, Moderna) or inactivated vaccines (Coronavac/Sinovac).
'If you are concerned about the risk of rare but serious side effects of vaccines such as GBS, you should know that receiving an mRNA COVID-19 vaccine does not appear to increase your risk, but infection with the virus does,' said Dr. Jeff Kwong, senior author for the study based at ICES and the University of Toronto in Canada. 'This study reinforces what we have known for some time—the potential health risks from COVID-19 disease are greater than the risks following COVID-19 vaccination, which plays an important role in protecting us from serious risks posed by infection.'
'Understanding the relative risks of vaccination and infection is critical. This study reinforces that while certain vaccines may carry small risks, SARS-CoV-2 infection itself presents a much greater threat to neurological health,' said Dr. Sharifa Nasreen, Assistant Professor at SUNY Downstate Health Sciences University, USA.
'Our findings emphasise that vaccine safety is not static—it is continuously studied and evaluated. The global research community remains committed to ensuring public confidence through ongoing safety monitoring and evidence-based guidance,' said Dr. Helen Petousis-Harris, GVDN Co-Director and Associate Professor at the University of Auckland.
GVDN collaborates with leading research institutions, policymakers, and vaccine organisations across six continents to create a comprehensive, evidence-based approach to vaccine safety and effectiveness. This large-scale study underscores the importance of vaccination as a tool for public health, not only in preventing severe disease but in reducing rare complications like GBS. Dr. Steve Black, GVDN Co-Director, stated, 'GVDN has long been committed to rigorous and transparent vaccine safety research. The size and diversity of this study population, attained through multinational collaboration, is a testament to this. Our findings highlight the importance of continuous monitoring and real-world data to guide public health decisions.'
About Global Vaccine Data Network™ (GVDN®)
Global Vaccine Data Network (GVDN) brings together researchers across six continents to deliver independent, real-world data on vaccine safety and effectiveness, supporting evidence-based public health decisions.
Established in 2019, GVDN collaborates with renowned research institutions, policy-makers, and vaccine-related organisations to establish a harmonised and evidence-based approach to evaluating vaccine safety and effectiveness using data sourced from millions of individuals across six continents. GVDN is supported by the Global Coordinating Centre based at Auckland UniServices Limited, a not-for-profit, stand-alone company that provides support to researchers and is wholly owned by the Waipapa Taumata Rau, University of Auckland. Aiming to gain a comprehensive understanding of vaccine safety and effectiveness profiles, GVDN strives to create a safer immunisation landscape that empowers decision-making for the global community. For further information, visit globalvaccinedatanetwork.org.
Disclaimer
This news release summarises the key findings of the GVDN study to identify the association between the risk of Guillain-Barré Syndrome (GBS) and COVID-19 infection or vaccination. To view the full publication in Vaccine, visit doi.org/10.1016/j.vaccine.2025.127291. This project was supported by the Centers for Disease Control and Prevention (CDC) of the U.S. Department of Health and Human Services (HHS). The contents are those of the authors and do not necessarily represent the official views of, nor an endorsement by, CDC/HHS, or the U.S. Government.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Otago Daily Times
18 hours ago
- Otago Daily Times
Record whale sightings off Kaikōura coast
There were 293 sightings of eight different cetacean species were observed, including humpback, sperm, blue and southern right whale. Photo: RNZ This year's Kaikōura whale count has been hailed as the best yet.A whopping 201 humpback whales were counted off the coast of Kaikōura during June. Kaikōura Ocean Research Institute (KORI) director Dr Jody Weir said the month-long whale count held in June attracted the most volunteers and sighted the most whales. ''It was awesome. It was our most brilliant season yet. We had 22 days suitable for viewing, weather-wise, and we had 173 volunteers who did a whopping 574 volunteer hours, which is the best we've had.'' First held in 2020 during Covid restrictions, the Great Kaikōura Whale Count has run on a shoe-string budget, kept alive by support from the Kaikōura District Council. But this year the coffers were boosted by sponsorship from South Pacific Helicopters, MainPower (North Canterbury's electricity network) and SeaWeek. Volunteers were out in force to count whales off Kaikōura's coast during June. Photo: Kaikōura Ocean Research Institute The extra funding allowed KORI to hire two interns, with masters degrees in marine biology, from mid-May to mid-July to plan and run the event, Dr Weir said. ''Those two interns were fabulous. They came from Italy and France. They were really wonderful and I hope we can get them back again.'' June is normally a quiet month for tourism, but it is the busiest time of year for humpback whales passing through. The event has proven to be a drawcard for visitors, who come to Kaikōura especially for the whale count, Dr Weir said. The project aims to get an idea of the number of whales migrating between feeding grounds in the Southern Ocean near Antarctica and breeding grounds in a more tropical climate. During the 22 days, there were 293 sightings of eight different cetacean species were observed, including humpback, sperm, blue and southern right whales, and dusky, common, Hector's and orca dolphins. This included 119 humpback whale sightings, counting 201 individual humpbacks, Dr Weir said. ''This year was really special as a baby humpback was born here in July. It is only the second or third time it has been recorded. ''It was also the first time we've seen a southern right whale from the hill, which is pretty cool.'' Community events were also held at Kaikōura Museum, a day of family activities at Fyffe House to mark World Oceans Day (June), a screening of the Oceans film at the Mayfair Arts and Culture Centre and a family fun day at Emporium Brewing. - By David Hill, Local Democracy Reporter • LDR is local body journalism co-funded by RNZ and NZ On Air.
Otago Daily Times
18 hours ago
- Otago Daily Times
Whopping season for whales
Kaikōura Ocean Research Institute (KORI) director Dr Jody Weir said the month-long whale count held in June attracted the most volunteers and sighted the most whales. ''It was awesome. It was our most brilliant season yet. We had 22 days suitable for viewing, weather-wise, and we had 173 volunteers who did a whopping 574 volunteer hours, which is the best we've had.'' First held in 2020 during Covid restrictions, the Great Kaikōura Whale Count has run on a shoe-string budget, kept alive by support from the Kaikōura District Council. But this year the coffers were boosted by sponsorship from South Pacific Helicopters, MainPower (North Canterbury's electricity network) and SeaWeek. The extra funding allowed KORI to hire two interns, with masters degrees in marine biology, from mid-May to mid-July to plan and run the event, Dr Weir said. ''Those two interns were fabulous. They came from Italy and France. They were really wonderful and I hope we can get them back again.'' June is normally a quiet month for tourism, but it is the busiest time of year for humpback whales passing through. The event has proven to be a drawcard for visitors, who come to Kaikōura especially for the whale count, Dr Weir said. The project aims to get an idea of the number of whales migrating between feeding grounds in the Southern Ocean near Antarctica and breeding grounds in a more tropical climate. During the 22 days, there were 293 sightings of eight different cetacean species were observed, including humpback, sperm, blue and southern right whales, and dusky, common, Hector's and orca dolphins. This included 119 humpback whale sightings, counting 201 individual humpbacks, Dr Weir said. ''This year was really special as a baby humpback was born here in July. It is only the second or third time it has been recorded. ''It was also the first time we've seen a southern right whale from the hill, which is pretty cool.'' Community events were also held at Kaikōura Museum, a day of family activities at Fyffe House to mark World Oceans Day (June), a screening of the Oceans film at the Mayfair Arts and Culture Centre and a family fun day at Emporium Brewing. - By David Hill, Local Democracy Reporter • LDR is local body journalism co-funded by RNZ and NZ On Air.
NZ Herald
2 days ago
- NZ Herald
Robert F. Kennedy jnr and American Academy of Pediatrics clash over Covid shots for kids
In an X post, Kennedy responded to the AAP's new vaccine recommendations by calling them 'corporate-friendly' and blasting the medical organisation for receiving donations from vaccine manufacturers. He said the organisation should disclose its 'corporate entanglements' and conflicts of interest 'so that Americans may ask whether the AAP's recommendations reflect public health interest, or are, perhaps, just a pay-to-play scheme to promote commercial ambitions of AAP's Big Pharma benefactors'. Susan Kressly, AAP's president, said her group welcomes an opportunity to meet Kennedy to discuss the recommendations. 'This attack on the integrity of paediatricians is unfortunate, but it does not change the facts,' Kressly said in a statement. 'We are transparent about our funders, follow rigorous conflict-of-interest disclosures and maintain safeguards to ensure the integrity and independence of our guidance.' The country is in the midst of a summer uptick in coronavirus cases, and the future of vaccine access is uncertain. The Centres for Disease Control and Prevention (CDC) did not go as far as Kennedy directed and did not remove coronavirus vaccines from the childhood immunisation schedule. Instead, the public health agency softened its recommendation for all children to receive an annual coronavirus shot. It now recommends parents consult a doctor to decide whether to vaccinate their children. The AAP took a similar approach for older children. Its new guide says healthy children ages 2 to 18 can receive a coronavirus vaccine if their parents or guardians want them to have that protection. Few parents do. The CDC estimates that 13% of all eligible children are up to date on coronavirus vaccines, as well as 4.5% of children between the ages of 6 months and 23 months. By issuing a broader coronavirus vaccine recommendation for young children, the AAP is trying to boost uptake and keep the shots free. Between October 2022 and April 2024, a little more than half of children between the ages of 6 months and 23 months admitted to intensive care for Covid had no underlying conditions, a CDC study found. Still, the vast majority of children infected by coronavirus will have mild symptoms, and few will become hospitalised. Health officials say it has become difficult to measure the effectiveness of coronavirus vaccines in young children because the vaccination rates are so low. Limited data shows the 2024-2025 coronavirus vaccines provided extra protection against severe illness in children and adults compared with people who did not receive a vaccine, according to CDC data presented in June. But paediatric infectious-disease specialists have argued that regularly vaccinating children makes sense as a public health strategy because evidence has shown each year that protection in children is similar to that seen in adults. Federal officials have yet to approve or recommend an updated coronavirus vaccine, which usually debuts in late summer. The Food and Drug Administration (FDA) has signalled it would not license upcoming coronavirus vaccines for otherwise healthy children. Kennedy recently fired all members of the CDC's Advisory Committee on Immunisation Practices, a group of experts who decide who should receive FDA-approved or authorised vaccines. Four of the seven members Kennedy appointed as replacements have been publicly critical of the broad use of coronavirus vaccines. For the past three decades, the AAP and the CDC have been mostly aligned in their vaccine recommendations – until now. The AAP's schedule 'differs from recent recommendations of the Advisory Committee on Immunisation Practices (Acip) of the CDC, which was overhauled this year and replaced with individuals who have a history of spreading vaccine misinformation', the organisation said in a statement. Retsef Levi, an Acip member who has denounced the use of mRNA coronavirus vaccines, criticised the AAP's recommendation in an X post, arguing Covid poses 'zero risk' to babies and the shots could damage their hearts. His message was reposted by Robert Malone, another Acip member who has been critical of coronavirus vaccines. Under federal law, insurers must cover the cost of Acip-recommended vaccinations. The AAP and other professional organisations have been holding discussions with insurance companies to continue covering the shots based on guidance from professional associations rather than the federal Government. O'Leary said insurers 'are signalling that they are committed to covering our recommendations'. Ahip (formerly America's Health Insurance Plans), the major insurance lobby, has said its members are committed to continuing to pay for respiratory virus vaccines this season. The new Acip panel did not make any coronavirus recommendations when it met for the first time in late June. It may not even convene a special meeting to discuss the coronavirus vaccines until mid-September, according to industry employees and CDC officials who spoke on the condition of anonymity to share sensitive information. That timing has become more uncertain after the August 8 shooting at the CDC that severely damaged several buildings and traumatised CDC staff. The Acip is scheduled to hold a meeting in October. The AAP's full vaccine guidance, published on Tuesday in the organisation's clinical guidebook for infectious-diseases prevention and treatment, represents formal recommendations for immunisations for infants, children and adolescents against 18 diseases. Its recommendations for flu and respiratory syncytial virus, or RSV, are essentially the same as what federal health officials, including Kennedy, have recommended.
